Drug Type Cell therapy |
Synonyms HANK cell Shenzhen Hank Bioengineering Institute, NK Immunotherapy(Shenzhen Hank Bioengineering Institute), Natural killer immunotherapy Shenzhen Hank Bioengineering Institute |
Target- |
Mechanism Immunologic cytotoxicity, Natural killer cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver metastases | Phase 2 | CN | 01 Jul 2016 | |
Recurrent Sarcoma | Phase 2 | CN | 01 Jul 2016 | |
Liver Cancer | Phase 2 | CN | 14 Jun 2016 | |
Sarcoma | Phase 2 | CN | 10 Jun 2016 |